Bullish View on Spruce Biosciences; Kroger Posts Mixed Results
- September 08th, 2023
- 425 views
Spruce Biosciences, Inc. (Nasdaq: SPRB), a pharmaceutical company, was upgraded from Market Perform to Outperform by SVB Leerink, accompanied by a revised price target increase from $3 to $9.
Given that $SPRB closed at $2.23 on Thursday, this adjusted price target suggests a potential upside of $6.77 per share or approximately 303.13%, based on the assessment by the investment firm.
In other news, The Kroger Co. (NYSE: KR), a major retail corporation, reported second-quarter 2023 earnings of $0.96 per share, surpassing the consensus EPS estimate of $0.91. The company's quarterly sales amounted to $33.85 billion, slightly below analysts' projected revenue of $34.13 billion for the period.
$KR was trading at $44.54 in pre-market, down $0.99 (-2.17%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
NJCP National Football Conference Names David Dalton Head Coach of Salt Lake Yeti
February 06th, 2026FDA Takes New Approach to "No Artificial Colors" Claims
February 06th, 2026NJCP National Football Conference Announces Micah Deckart as Head Coach of the Idaho Outlaws
February 05th, 2026
Member Login